Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
A Phase 3, Randomized, Double-Blind, Comparative Study of Micafungin (FK463) Versus Caspofungin as Antifungal Treatment in Patients With Invasive Candidiasis or Candidemia
1 other identifier
interventional
611
15 countries
167
Brief Summary
The purpose of the study is to determine the safety and effectiveness of two dose levels of micafungin versus caspofungin in the treatment of proven invasive candidiasis or candidemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Sep 2004
167 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2004
CompletedFirst Submitted
Initial submission to the registry
March 7, 2005
CompletedFirst Posted
Study publicly available on registry
March 8, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedSeptember 18, 2014
September 1, 2014
1.6 years
March 7, 2005
September 17, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall treatment success, based on the investigator's assessment of pre-defined clinical and mycological response at the End of intravenous (IV) Therapy
End of therapy and 6 weeks post-treatment
Secondary Outcomes (1)
Overall treatment success, based on the Data Review Panel's assessment of pre-defined clinical and mycological response at the End of IV Therapy
End of therapy and 6 weeks post-treatment
Study Arms (3)
1
EXPERIMENTALlower dose
2
EXPERIMENTALhigher dose
3
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Patients must have candidemia or invasive candidiasis.
You may not qualify if:
- Patients who have received an echinocandin within one month prior to study entry.
- Patients who have received more than two days of prior systemic antifungal therapy for the current infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (167)
Unknown Facility
Birmingham, Alabama, 35294, United States
Unknown Facility
Little Rock, Arkansas, 72205, United States
Unknown Facility
Los Angeles, California, 90033, United States
Unknown Facility
Los Angeles, California, 90095, United States
Unknown Facility
San Francisco, California, 94115, United States
Unknown Facility
Denver, Colorado, 80204, United States
Unknown Facility
Denver, Colorado, 80262, United States
Unknown Facility
Washington D.C., District of Columbia, 20010, United States
Unknown Facility
Bay Pines, Florida, 33744, United States
Unknown Facility
Miami, Florida, 33136, United States
Unknown Facility
Atlanta, Georgia, 30322, United States
Unknown Facility
Augusta, Georgia, 30909, United States
Unknown Facility
Augusta, Georgia, 30912, United States
Unknown Facility
Chicago, Illinois, 60612, United States
Unknown Facility
Chicago, Illinois, 60637, United States
Unknown Facility
Maywood, Illinois, 60153, United States
Unknown Facility
Beech Grove, Indiana, 46107, United States
Unknown Facility
Evansville, Indiana, 47714, United States
Unknown Facility
Des Moines, Iowa, 50309, United States
Unknown Facility
Iowa City, Iowa, 52242, United States
Unknown Facility
Kansas City, Kansas, 66160, United States
Unknown Facility
Wichita, Kansas, 67214, United States
Unknown Facility
Lexington, Kentucky, 40536, United States
Unknown Facility
New Orleans, Louisiana, 70121, United States
Unknown Facility
Baltimore, Maryland, 21201, United States
Unknown Facility
Baltimore, Maryland, 21287, United States
Unknown Facility
Boston, Massachusetts, 02111, United States
Unknown Facility
Boston, Massachusetts, 02115, United States
Unknown Facility
Boston, Massachusetts, 02215, United States
Unknown Facility
Detroit, Michigan, 48201, United States
Unknown Facility
Detroit, Michigan, 48202, United States
Unknown Facility
Minneapolis, Minnesota, 55455, United States
Unknown Facility
Jackson, Mississippi, 39216, United States
Unknown Facility
St Louis, Missouri, 63310, United States
Unknown Facility
Neptune City, New Jersey, 07754, United States
Unknown Facility
Albany, New York, 12208, United States
Unknown Facility
Manhasset, New York, 11030, United States
Unknown Facility
New Hyde Park, New York, 11040, United States
Unknown Facility
New York, New York, 10029, United States
Unknown Facility
New York, New York, 10032, United States
Unknown Facility
Rochester, New York, 14642, United States
Unknown Facility
Stony Brook, New York, 11794, United States
Unknown Facility
The Bronx, New York, 10467, United States
Unknown Facility
Valhalla, New York, 10595, United States
Unknown Facility
Durham, North Carolina, 27710, United States
Unknown Facility
Winston-Salem, North Carolina, 27157, United States
Unknown Facility
Cincinnati, Ohio, 45267, United States
Unknown Facility
Columbus, Ohio, 43210, United States
Unknown Facility
Allentown, Pennsylvania, 18103, United States
Unknown Facility
Philadelphia, Pennsylvania, 19104, United States
Unknown Facility
Philadelphia, Pennsylvania, 19140, United States
Unknown Facility
Pittsburgh, Pennsylvania, 15213, United States
Unknown Facility
West Reading, Pennsylvania, 19611, United States
Unknown Facility
Providence, Rhode Island, 02908, United States
Unknown Facility
Jackson, Tennessee, 38301, United States
Unknown Facility
Memphis, Tennessee, 38104, United States
Unknown Facility
Dallas, Texas, 75246, United States
Unknown Facility
Houston, Texas, 77030, United States
Unknown Facility
San Antonio, Texas, 78229, United States
Unknown Facility
Charlottesville, Virginia, 22908, United States
Unknown Facility
Fairfax, Virginia, 22030, United States
Unknown Facility
Seattle, Washington, 98109, United States
Unknown Facility
Vienna, 1090, Austria
Unknown Facility
Aalst, 9300, Belgium
Unknown Facility
Brussels, 1000, Belgium
Unknown Facility
Brussels, 1070, Belgium
Unknown Facility
Brussels, 1090, Belgium
Unknown Facility
Brussels, 1200, Belgium
Unknown Facility
Ghent, 9000, Belgium
Unknown Facility
Liège, 4800, Belgium
Unknown Facility
Belo Horizonte, Mg-cep, 30140-093, Brazil
Unknown Facility
Belo Horizonte, Mg-cep, 30190-081, Brazil
Unknown Facility
Belo Horizonte, Minas Gerais, 30190-081, Brazil
Unknown Facility
Cunitiba, Pr-cep, 80060-900, Brazil
Unknown Facility
Rio de Janeiro, Rio de Janeiro, 21941-590, Brazil
Unknown Facility
Porto Alegre, Rio Grande do Sul, Brazil
Unknown Facility
Santos, SĂ£o Paulo, 11045-904, Brazil
Unknown Facility
SĂ£o JosĂ© do Rio Preto, SĂ£o Paulo, 15090-000, Brazil
Unknown Facility
SĂ£o Paulo, SĂ£o Paulo, 04039-020, Brazil
Unknown Facility
Belo Horizonte, 30110-908, Brazil
Unknown Facility
Belo Horizonte, 30130-110, Brazil
Unknown Facility
Belo Horizonte, 30190-130, Brazil
Unknown Facility
Salvador, 40050-410, Brazil
Unknown Facility
Salvador, 40110-160, Brazil
Unknown Facility
SĂ£o Paulo, 01500-000, Brazil
Unknown Facility
SĂ£o Paulo, 04012-180, Brazil
Unknown Facility
SĂ£o Paulo, 04040-002, Brazil
Unknown Facility
Edmonton, Alberta, T6G 2B7, Canada
Unknown Facility
Kelowna, British Columbia, V1Y 1T2, Canada
Unknown Facility
Winnipeg, Manitoba, R3A 1R9, Canada
Unknown Facility
St. John's, Newfoundland and Labrador, A1B 3V6, Canada
Unknown Facility
Halifax, Nova Scotia, B3H 1V7, Canada
Unknown Facility
Hamilton, Ontario, L8V 1C3, Canada
Unknown Facility
Kingston, Ontario, K7L 2V7, Canada
Unknown Facility
Ottawa, Ontario, K1H 8L6, Canada
Unknown Facility
Toronto, Ontario, M5G 2N2, Canada
Unknown Facility
Chicoutimi, Quebec, G7H 5H6, Canada
Unknown Facility
Greenfield Park, Quebec, J4V 2H1, Canada
Unknown Facility
Montreal, Quebec, H1T 2M4, Canada
Unknown Facility
Montreal, Quebec, H2X 2P4, Canada
Unknown Facility
Québec, Quebec, G1R 2J6, Canada
Unknown Facility
Regina, Saskatchewan, S4P 0W5, Canada
Unknown Facility
Saskatoon, Saskatchewan, S7N 0W8, Canada
Unknown Facility
Zagreb, 10000, Croatia
Unknown Facility
Prague, 14021, Czechia
Unknown Facility
Bobigny, 93009, France
Unknown Facility
Metz, 57000, France
Unknown Facility
Paris, 75181, France
Unknown Facility
Paris, 75651, France
Unknown Facility
Paris, 75674, France
Unknown Facility
Paris, 75877, France
Unknown Facility
Strasbourg, 67098, France
Unknown Facility
Villejuif, 94084, France
Unknown Facility
Villejuif, 94805, France
Unknown Facility
Berlin, 10117, Germany
Unknown Facility
Bielefeld, 33611, Germany
Unknown Facility
Cologne, 50937, Germany
Unknown Facility
Frankfurt, 60590, Germany
Unknown Facility
Hanover, 30625, Germany
Unknown Facility
Ulm, 89081, Germany
Unknown Facility
WĂ¼rzburg, 97070, Germany
Unknown Facility
Bangalore, 560017, India
Unknown Facility
Bangalore, 56017, India
Unknown Facility
Bangalore, India
Unknown Facility
Banglore, 560 054, India
Unknown Facility
Chandigarh, India
Unknown Facility
Chennai, 35, India
Unknown Facility
Chennai, 600 006, India
Unknown Facility
Cochin Kerala, 682 026, India
Unknown Facility
Hyderabad, 500 009, India
Unknown Facility
Hyderabad, 500 033, India
Unknown Facility
Hyderabad, 500 034, India
Unknown Facility
Hyderabad, 500 082, India
Unknown Facility
Kochi, India
Unknown Facility
Kolkotta, 700 029, India
Unknown Facility
Lucknow, 226 014, India
Unknown Facility
Ludhiana, 141 009, India
Unknown Facility
Mangalore, 575 001, India
Unknown Facility
Manipal, 576 104, India
Unknown Facility
Mumbai, 400 012, India
Unknown Facility
Mumbai, 400 026, India
Unknown Facility
Uttar Pradesh, 201 301, India
Unknown Facility
Groningen, 9700 RB, Netherlands
Unknown Facility
Gdansk, 80-211, Poland
Unknown Facility
Lodz, 93-513, Poland
Unknown Facility
Warsaw, 00-957, Poland
Unknown Facility
Barakaldo, 48903, Spain
Unknown Facility
Barcelona, 08003, Spain
Unknown Facility
Barcelona, 08025, Spain
Unknown Facility
Barcelona, 08035, Spain
Unknown Facility
Barcelona, 08036, Spain
Unknown Facility
Madrid, 28005, Spain
Unknown Facility
Madrid, 28007, Spain
Unknown Facility
Madrid, 28034, Spain
Unknown Facility
Madrid, 28041, Spain
Unknown Facility
Salamanca, 37007, Spain
Unknown Facility
Santander, 39008, Spain
Unknown Facility
Seville, 41014, Spain
Unknown Facility
Valencia, 46009, Spain
Unknown Facility
Sankt Gallen, 9007, Switzerland
Unknown Facility
London, England, SE1 7EH, United Kingdom
Unknown Facility
London, England, SW10 9NH, United Kingdom
Unknown Facility
London, England, W6 8RF, United Kingdom
Unknown Facility
Manchester, England, M23 9LT, United Kingdom
Unknown Facility
Glasgow, GB, G11 6NT, United Kingdom
Unknown Facility
Leeds, GB, LS1 3EX, United Kingdom
Unknown Facility
Leeds, GB, LS9 7TF, United Kingdom
Related Publications (2)
Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis. 2007 Oct 1;45(7):883-93. doi: 10.1086/520980. Epub 2007 Aug 29.
PMID: 17806055BACKGROUNDShorr AF, Wu C, Kothari S. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei. J Antimicrob Chemother. 2011 Feb;66(2):375-80. doi: 10.1093/jac/dkq446. Epub 2010 Dec 8.
PMID: 21147825DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Central Contact
Astellas Pharma US, Inc.
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2005
First Posted
March 8, 2005
Study Start
September 1, 2004
Primary Completion
April 1, 2006
Study Completion
April 1, 2006
Last Updated
September 18, 2014
Record last verified: 2014-09